| Literature DB >> 21609454 |
Marjorie F Oleksiak1, Sibel I Karchner, Matthew J Jenny, Diana G Franks, David B Mark Welch, Mark E Hahn.
Abstract
BACKGROUND: Populations of Atlantic killifish (Fundulus heteroclitus) have evolved resistance to the embryotoxic effects of polychlorinated biphenyls (PCBs) and other halogenated and nonhalogenated aromatic hydrocarbons that act through an aryl hydrocarbon receptor (AHR)-dependent signaling pathway. The resistance is accompanied by reduced sensitivity to induction of cytochrome P450 1A (CYP1A), a widely used biomarker of aromatic hydrocarbon exposure and effect, but whether the reduced sensitivity is specific to CYP1A or reflects a genome-wide reduction in responsiveness to all AHR-mediated changes in gene expression is unknown. We compared gene expression profiles and the response to 3,3',4,4',5-pentachlorobiphenyl (PCB-126) exposure in embryos (5 and 10 dpf) and larvae (15 dpf) from F. heteroclitus populations inhabiting the New Bedford Harbor, Massachusetts (NBH) Superfund site (PCB-resistant) and a reference site, Scorton Creek, Massachusetts (SC; PCB-sensitive).Entities:
Mesh:
Substances:
Year: 2011 PMID: 21609454 PMCID: PMC3213123 DOI: 10.1186/1471-2164-12-263
Source DB: PubMed Journal: BMC Genomics ISSN: 1471-2164 Impact factor: 3.969
Figure 1Experimental design and effect of PCB treatment on expression of CYP1A. A. Experimental design for treatment and sampling. Killifish embryos (4 hpf) were exposed to DMSO or PCB-126 (50 nM) for 1 hr. Sampling was at 5, 10, or 15 dpf. See Methods for additional details. B. Expression of CYP1A as measured by real-time RT-PCR. Results (means ± standard deviations of 3 biological replicates) are normalized to expression of beta-actin and expressed relative to the DMSO-treated control in each group. *Statistically significant difference vs. DMSO-treated controls at the same sampling time.
Figure 2Heat map illustrating results of hierarchical clustering of the genes whose expression is significantly different due to population, treatment and population-by-treatment interactions at 5, 10, and 15 days post-fertilization. Clusters of genes with similar expression patterns are shown on the left (gene tree). Red indicates high expression levels and green represents low expression levels. Black rectangles denote genes significantly differently expressed at 5, 10, and 15 days post-fertilization. Orange rectangles denote genes significantly differently expressed at 5 and 10 days post-fertilization. Blue rectangles denote genes significantly differently expressed at 5 and 15 days post-fertilization. Purple rectangles denote genes significantly differently expressed at 10 and 15 days post-fertilization. Unlabeled rectangles represent unannotated genes.
Figure 3Correlations and network interactions of genes whose expression is significantly different due to population, treatment and population-by-treatment interactions at 5, 10 and 15 days post-fertilization. Correlation coefficients > 0.95 and < -0.95 are significant at p < 0.01. Red indicates positive correlations and blue indicates negative correlations. In the gene networks, red lines connect genes with significant positive correlations and blue lines connect genes with significant negative correlations (p < 0.01). Green ovals denote CYP1A in the different networks. Because of the complexity of the networks at 15 days post-fertilization, only the network of genes with significant interactions with CYP1A is shown.
Figure 4Number of genes exhibiting statistically significant differences in expression in pairwise comparisons of NBH PCB vs NBH DMSO, SC PCB vs SC DMSO, and NBH DMSO vs SC DMSO. The size of the circles reflects the number of genes in each group. Numbers on lines indicate number of genes shared between the groups. See Table 1 and Additional file 4: Table S2 for gene lists.
Differential gene expression and PCB inducibility in pairwise comparisons of NBH and SC embryos at 5 and 10 dpf.
| Gene | NBH PCB/NBH DMSO | SC PCB/SC DMSO | NBH DMSO/SC DMSO |
|---|---|---|---|
| basic leucine zipper nuclear factor 1 [Mus musculus]_603 | -1.03 | -1.52 | |
| Cytochrome P450 1A1 (EC 1.14.14.1) (CYP1A)_1115 | 1.29 | -1.12 | |
| *UnAn_29411_6378 (CYP1B1) | -1.03 | -2.51 | |
| T-cell surface glycoprotein CD3 delta chain precursor (T-cell receptor T3 delta chain)_3770 | 1.14 | -1.64 | |
| *UnAn_27910_5543 (CYP1B1) | 1.22 | -1.32 | |
| Diablo homolog, mitochondrial precursor (Second mitochondria-derived activator of caspase) (Smac protein) (Direct IAP binding protein with low pI)_1191 | -1.03 | 2.14 | |
| UnAn_21996_4295 | 1.28 | 1.02 | |
| Small inducible cytokine A4 homolog precursor (Macrophage inflammatory protein 1-beta homolog)_3581 | 1.13 | 1.03 | |
| Synaptophysin-like protein (Pantophysin)_3753 | -1.15 | 1.64 | |
| ATP synthase lipid-binding protein, mitochondrial precursor (EC 3.6.3.14) (ATP synthase proteolipid P2) (ATPase protein 9) (ATPase subunit C)_560 | 1.31 | 1.47 | |
| Hypothetical protein C31G5.21 in chromosome I_1963 | 1.12 | 1.27 | |
| hect domain and RLD 4 isoform b [Homo sapiens]_1806 | 1.21 | -1.06 | |
| UnAn_26723_4896 | -1.14 | 1.14 | |
| UnAn_23246_4614 | -1.09 | 1.03 | |
| UnAn_22726_4401 | 1.03 | -1.10 | |
| Proteasome subunit beta type 7 precursor (EC 3.4.25.1) (Proteasome subunit Z) (Macropain chain Z) (Multicatalytic endopeptidase complex chain Z)_3109 | -1.10 | -1.14 | |
| Deoxyribonuclease-1 precursor (EC 3.1.21.1) (Deoxyribonuclease I) (DNase I)_1181 | 1.48 | -1.14 | |
| Guanidinoacetate N-methyltransferase (EC 2.1.1.2)_1754 | -1.16 | -1.25 | |
| *UnAn_29411_6378 (CYP1B1) | 1.09 | 1.12 | |
| Cytochrome P450 1A1 (EC 1.14.14.1) (CYP1A)_1115 | 1.10 | -1.13 | |
| T-cell surface glycoprotein CD3 delta chain precursor (T-cell receptor T3 delta chain)_3770 | 1.07 | -1.25 | |
| *UnAn_27910_5543 (CYP1B1) | -1.02 | -1.29 | |
| Tubulointerstitial nephritis antigen-like precursor (Androgen-regulated gene protein 1) (Adrenocortical zonation factor 1) (AZ-1) (Tubulointersititial nephritis antigen-related protein) (TARP)_4042 | 1.49 | -1.03 | |
| **UnAn_29159_6257 (apolipoprotein E) | 1.18 | -1.20 | |
| **UnAn_28041_5632 (apolipoprotein E) | 1.02 | -1.01 | |
| Acidic phosphoprotein precursor (50 kDa antigen)_277 | 1.11 | -1.15 | |
| **UnAn_23610r_4780 (apolipoprotein E) | 1.06 | -1.45 | |
| UnAn_21996_4295 | -1.15 | -1.01 | |
| Apomucin (Mucin core protein) (Fragment)_492 | 1.16 | 1.45 | |
| C61 protein [Mus musculus]_684 | 1.22 | 1.84 | |
| WAP four-disulfide core domain protein 3 precursor (Putative protease inhibitor WAP14)_6790 | 1.02 | 1.59 | |
| Tyrosine aminotransferase (EC 2.6.1.5) (L-tyrosine:2-oxoglutarate aminotransferase) (TAT)_4064 | -1.14 | -1.24 | |
| MHC class II transactivator (CIITA)_2363 | 1.03 | -1.06 | |
| UnAn_23121_4564 | -1.09 | 1.54 | |
| Troponin C, slow skeletal and cardiac muscles (TN-C)_3995 | 1.08 | 1.63 | |
| Epsin-4 (Epsin-related protein) (EpsinR) (Enthoprotin)_1384 | 1.38 | 2.03 | |
| UnAn_27985_5592 | -1.10 | 1.13 | |
| AMP deaminase 1 (EC 3.5.4.6) (Myoadenylate deaminase) (AMP deaminase isoform M)_431 | 1.27 | 1.49 | |
| UnAn_29343_6349 | 1.20 | 1.48 | |
| UnAn_29849_6655 | 1.11 | 1.24 | |
| Cathepsin D precursor (EC 3.4.23.5)_755 | 1.04 | 1.01 | |
| UnAn_22785_4432 | -1.24 | -1.01 | |
| UnAn_20648_4152 | -1.05 | 1.01 | |
| Mitogen-activated protein kinase kinase 1 interacting protein 1 (MEK binding partner 1) (Mp1)_2424 | -1.10 | -1.07 | |
| Epididymal secretory glutathione peroxidase precursor (EC 1.11.1.9) (Epididymis-specific glutathione peroxidase-like protein) (EGLP)_1378 | -1.15 | -1.32 | |
| Muted protein homolog_2461 | -1.16 | -1.50 | |
| UnAn_22879_4456 | -1.20 | -1.51 | |
| UnAn_22354_4332 | -1.09 | -1.28 | |
| Type II antifreeze protein precursor (AFP)_4059 | -1.12 | -1.30 | |
| T-cell surface glycoprotein CD8 beta chain precursor (CD8 antigen 37 kDa chain) (OX-8 membrane antigen)_3771 | -1.32 | -1.12 | |
| UnAn_20957_4180 | -1.32 | -1.48 | |
| Chromobox protein homolog 2 (Modifier 3 protein) (M33)_827 | -1.47 | -1.36 | |
| Beta enolase (EC 4.2.1.11) (2-phospho-D-glycerate hydro-lyase) (Muscle-specific enolase) (MSE) (Skeletal muscle enolase) (Enolase 3)_620 | -1.00 | -1.29 | |
| UnAn_27466_5284 | 1.30 | -1.33 | |
| Transcription factor PU.1_3890 | 1.19 | -1.36 | |
| UnAn_22873_4452 | -1.00 | 1.30 | |
| RWD domain containing protein 1 (Small androgen receptor-interacting protein)_3458 | 1.05 | -1.05 | |
| Parvalbumin beta_2778 | 1.30 | -1.49 | |
Genes with significant differences in pairwise comparisons of gene expression at 5 and 10 dpf are included. (For 15-dpf data, see Additional file 4: Table S2.) Gene expression ratios are indicated. A gene with a positive fold-difference is more highly expressed in the population/treatment listed first, and a gene with a negative fold-difference is more highly expressed in the population/treatment listed last. Genes are listed in order of ratios in the reference population (SC) comparison with tolerant population (SC). Ratios with significant p-values are in bold. See Table S1 (Additional file 2) for a list of all genes significant in the ANOVA analysis. NBH: New Bedford Harbor; SC: Scorton Creek; PCB: PCB-126; DMSO: dimethylsulfoxide. Unannotated genes are denoted by UnAn and a unique number. Some of the unannotated probes were subsequently annotated after extension using the 454 database; see Table S4 (Additional file 6) for details.
*These two probes represent the same transcript, which has been annotated as cytochrome P450 1B1 (CYP1B1) using data from 454 libraries.
** These three probes represent the same transcript, which has been annotated as apolipoprotein E using data from 454 libraries.
aAlso differentially expressed at 5 dpf.
bAlso differentially expressed at 10 dpf.
cAlso differentially expressed at 15 dpf.
Differential gene expression in 10-dpf NBH and SC embryos as measured by RNA-Seq.
| Gene | SC-DMSO | SC-PCB | NBH-DMSO | NBH-PCB |
|---|---|---|---|---|
| UnAn_29411_6378* (CYP1B1) # | 0 | 66 | 0 | 0 |
| Cytochrome P450 1A1 (EC 1.14.14.1) (CYPIA1)_1115 # | 0 | 4987 | 0 | 3 |
| T-cell surface glycoprotein CD3 delta chain precursor (T-cell receptor T3 delta chain)_3770 # | 0 | 0 | 0 | 0 |
| UnAn_27910_5543* (CYP1B1) # | 0 | 66 | 0 | 0 |
| Tubulointerstitial nephritis antigen-like precursor (Androgen-regulated gene protein 1) (Adrenocortical zonation factor 1) (AZ-1) (Tubulointersititial nephritis antigen-related protein) (TARP)_4042 # | 1 | 0 | 3 | 6 |
| UnAn_29159_6257** (apolipoprotein E) # | 41 | 177 | 52 | 37 |
| UnAn_28041_5632** (apolipoprotein E) # | 41 | 177 | 52 | 37 |
| Acidic phosphoprotein precursor (50 kDa antigen)_277 # | 0 | 0 | 0 | 0 |
| UnAn_23610r_4780** (apolipoprotein E) # | 41 | 177 | 52 | 37 |
| UnAn_21996_4295 # | 0 | 0 | 0 | 0 |
| Apomucin (Mucin core protein) (Fragment)_492 # | 18 | 31 | 8 | 10 |
| C61 protein [Mus musculus]_684 # | 0 | 0 | 0 | 2 |
| WAP four-disulfide core domain protein 3 precursor (Putative protease inhibitor WAP14)_6790 # | 0 | 0 | 0 | 0 |
| Tyrosine aminotransferase (EC 2.6.1.5) (L-tyrosine:2-oxoglutarate aminotransferase) (TAT)_4064 # | 0 | 0 | 0 | 0 |
| MHC class II transactivator (CIITA)_2363 # | 0 | 0 | 0 | 0 |
| UnAn_23121_4564 # | 2 | 0 | 3 | 0 |
| Troponin C, slow skeletal and cardiac muscles (TN-C)_3995 | 13 | 26 | 22 | 14 |
| Epsin-4 (Epsin-related protein) (EpsinR) (Enthoprotin)_1384 # | 0 | 0 | 0 | 0 |
| UnAn_27985_5592 # | 19 | 10 | 14 | 11 |
| AMP deaminase 1 (EC 3.5.4.6) (Myoadenylate deaminase) (AMP deaminase isoform M)_431 # | 0 | 0 | 0 | 0 |
| UnAn_29343_6349 # | 134 | 179 | 92 | 137 |
| UnAn_29849_6655 | 2 | 0 | 0 | 0 |
| Cathepsin D precursor (EC 3.4.23.5)_755 | 0 | 0 | 1 | 0 |
| UnAn_22785_4432 | 129 | 103 | 77 | 135 |
| UnAn_20648_4152 | 5 | 0 | 9 | 8 |
| Mitogen-activated protein kinase kinase 1 interacting protein 1 (MEK binding partner 1) (Mp1)_2424 | 11 | 7 | 5 | 13 |
| Epididymal secretory glutathione peroxidase precursor (EC 1.11.1.9) (Epididymis-specific glutathione peroxidase-like protein) (EGLP)_1378 | 3 | 4 | 0 | 1 |
| Muted protein homolog_2461 | 22 | 5 | 4 | 7 |
| UnAn_22879_4456 | 50 | 35 | 42 | 32 |
| UnAn_22354_4332 | 12 | 22 | 32 | 25 |
| Type II antifreeze protein precursor (AFP)_4059 | 2 | 1 | 2 | 0 |
| T-cell surface glycoprotein CD8 beta chain precursor (CD8 antigen 37 kDa chain) (OX-8 membrane antigen)_3771 | 11 | 9 | 13 | 12 |
| UnAn_20957_4180 | 0 | 0 | 1 | 2 |
| Chromobox protein homolog 2 (Modifier 3 protein) (M33)_827 | 0 | 0 | 0 | 0 |
| Beta enolase (EC 4.2.1.11) (2-phospho-D-glycerate hydro-lyase) (Muscle-specific enolase) (MSE) (Skeletal muscle enolase) (Enolase 3)_620 | 18 | 15 | 18 | 20 |
| UnAn_27466_5284 | 12 | 12 | 14 | 19 |
| Transcription factor PU.1_3890 | 0 | 0 | 0 | 0 |
| UnAn_22873_4452 | 0 | 0 | 0 | 0 |
| RWD domain containing protein 1 (Small androgen receptor-interacting protein)_3458 | 15 | 9 | 10 | 1 |
| Parvalbumin beta_2778 | 49 | 44 | 40 | 60 |
The probe sequences representing genes with significant differences in pairwise comparisons in the 10-dpf samples (see Table 1) were used in blast searches against a database of the reads from each EST library using BlastStation-Local (version 1.4). The number of reads matching each probe sequence is indicated. The e-value cut-off was approximately 1x10-20, and the percent identity limit was set as 90% or higher. NBH: New Bedford Harbor; SC: Scorton Creek; PCB: PCB-126; DMSO: dimethylsulfoxide. Unannotated genes are denoted by UnAn and a unique number. The probes labeled with asterisks (* or **) belong to the same transcript, and therefore share the same 454 read counts. Some of the unannotated probes were subsequently annotated after extension using the 454 database; see Table S4 (Additional file 6) for details. Probes labeled with "#" are those exhibiting significant induction by PCB in SC embryos but not NBH embryos in the microarray analysis (see Table 1).